Status:
COMPLETED
Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology
Lead Sponsor:
Children's Mercy Hospital Kansas City
Collaborating Sponsors:
University of Kansas
Conditions:
Lung Disease
Brain Injury
Eligibility:
All Genders
Brief Summary
This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Nec...
Detailed Description
This genetic predisposition study does not involve investigational drugs, devices, or treatments. Our broad goal is to identify genomic factors, which contribute to the development or exacerbation of ...
Eligibility Criteria
Inclusion
- Less than 34 weeks gestation and less than 1500 g at birth
- Greater than or equal to 36 weeks gestation and either with hypoxic respiratory failure or with mild respiratory distress never requiring assisted ventilation
Exclusion
- Life threatening anomalies of any organ system (e.g., cardiac, thoracic, lethal, or non-lethal chromosomal abnormalities)
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00315263
Start Date
April 1 2006
End Date
July 1 2011
Last Update
August 26 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States, 64108
2
Truman Medical Center
Kansas City, Missouri, United States, 64108